Compare Colgate-Palmolive Company (CL) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs JPMorgan Chase & Co — how do they compare? Colgate-Palmolive Company trades at $91.1 (market cap $72.84B), while JPMorgan Chase & Co trades at $343.66 (market cap $911.47B). The key difference: JPMorgan Chase & Co is far larger — about 12.5× Colgate-Palmolive Company's market cap, and Colgate-Palmolive Company pays the higher dividend (2.33%). Which is the better fit depends on your goals.
| CL | JPM | |
|---|---|---|
Market Cap | $72.84B | $911.47B |
Sector | Consumer Staples | Financials |
52-Week High | $99.14 | $342.89 |
52-Week Low | $74.98 | $282.84 |
Enterprise Value | $79.48B | — |
Dividend Yield | 2.33% | 1.75% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.21, up 1.05% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 60.06% gross margins and 822.05% ROE, though valuation metrics appear elevated with a P/E of 36.13. Recent dividend declarations and positive analyst coverage (42% buy rating) support the defensive stock's appeal amid market rotation into stable cash flow names.
Outlook remains positive with a $97 consensus price target representing 4% upside, though premium valuation and North American segment softness present headwinds. The company's 64-year dividend growth streak and global diversification provide stability, while inflation pressures and competitive threats require monitoring for sustained outperformance.
JPMorgan Chase (JPM) trades at $334.53, down 0.58% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q1 and Q2 2026 earnings beats, with Q1 EPS of $5.94 versus $5.47 expected and Q2 EPS of $7.7 versus $5.59 expected, though Q4 2025 missed expectations. Revenue grew to $181.85B in 2025, with a net income margin of 31.61% and ROE of 17.03%. Analyst consensus is a Moderate Buy with a $369.67 price target, and recent news highlights CEO Jamie Dimon's economic warnings and upcoming bank earnings focus.
JPMorgan's outlook remains positive driven by earnings momentum and solid profitability, but risks include geopolitical tensions, cybersecurity threats from AI, and macroeconomic volatility cited by management. The stock offers potential upside to the consensus target, supported by institutional buying interest, though investors should weigh elevated debt levels and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
